BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 21079037)

  • 1. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.
    Chun J; Hla T; Lynch KR; Spiegel S; Moolenaar WH
    Pharmacol Rev; 2010 Dec; 62(4):579-87. PubMed ID: 21079037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.
    Chun J; Goetzl EJ; Hla T; Igarashi Y; Lynch KR; Moolenaar W; Pyne S; Tigyi G
    Pharmacol Rev; 2002 Jun; 54(2):265-9. PubMed ID: 12037142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophospholipid receptor nomenclature review: IUPHAR Review 8.
    Kihara Y; Maceyka M; Spiegel S; Chun J
    Br J Pharmacol; 2014 Aug; 171(15):3575-94. PubMed ID: 24602016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
    Im DS
    Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
    Meyer zu Heringdorf D; Jakobs KH
    Biochim Biophys Acta; 2007 Apr; 1768(4):923-40. PubMed ID: 17078925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases.
    Chun J; Rosen H
    Curr Pharm Des; 2006; 12(2):161-71. PubMed ID: 16454733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophospholipids and their receptors in the central nervous system.
    Choi JW; Chun J
    Biochim Biophys Acta; 2013 Jan; 1831(1):20-32. PubMed ID: 22884303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
    Takuwa Y; Takuwa N; Sugimoto N
    J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
    Chun J; Contos JJ; Munroe D
    Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophospholipid receptor-dependent and -independent calcium signaling.
    Meyer Zu Heringdorf D
    J Cell Biochem; 2004 Aug; 92(5):937-48. PubMed ID: 15258917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
    Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
    Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
    Goetzl EJ; Kong Y; Mei B
    J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate.
    Fueller M; Wang DA; Tigyi G; Siess W
    Cell Signal; 2003 Apr; 15(4):367-75. PubMed ID: 12618211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Union of Pharmacology. XLVI. G protein-coupled receptor list.
    Foord SM; Bonner TI; Neubig RR; Rosser EM; Pin JP; Davenport AP; Spedding M; Harmar AJ
    Pharmacol Rev; 2005 Jun; 57(2):279-88. PubMed ID: 15914470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
    Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
    J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.
    Fleming JK; Glass TR; Lackie SJ; Wojciak JM
    J Lipid Res; 2016 Sep; 57(9):1737-47. PubMed ID: 27444045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages.
    Duong CQ; Bared SM; Abu-Khader A; Buechler C; Schmitz A; Schmitz G
    Biochim Biophys Acta; 2004 Jun; 1682(1-3):112-9. PubMed ID: 15158762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.
    Lee H; Goetzl EJ; An S
    Am J Physiol Cell Physiol; 2000 Mar; 278(3):C612-8. PubMed ID: 10712250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification and characterization of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.
    An S
    Ann N Y Acad Sci; 2000 Apr; 905():25-33. PubMed ID: 10818439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.